Abstract:Purpose: Recent evidence indicates that a major drawback of current cartilage and intervertebral disc (IVD) tissue engineering is that human mesenchymal stem cells (MSCs) from osteoarthritic patients rapidly express type X collagen (COL10A1), a marker of late-stage chondrocyte hypertrophy associated with endochondral ossification. We recently discovered that a novel atmospheric-pressure plasma-polymerized thin film substrate, named “nitrogen-rich plasma-polymerized ethylene” (PPE:N), is able to inhibit COL10A1 expression in committed MSCs. However, the cellular mechanisms implicated in the inhibition of COL10A1 expression by PPE:N surfaces are unknown. Method: Human mesenchymal stem cells (MSCs) were obtained from aspirates from the intramedullary canal of donors (60–80 years of age) undergoing total hip replacement for osteoarthritis. Bone marrow aspirates were processed and MSCs were cultured on commercial polystyrene (PS control) and on PPE:N surfaces in the presence of different kinases and cyclooxygenase inhibitors for 3 days. Total RNA was extracted with TRIzol reagent (Invitrogen, Burlington, ON) and the expression of COL10A1, cyclooxygenase-1 (COX-1), and 5-lipoxygenase (5-LOX) genes was measured by real-time quantitative RT-PCR. Results: Results showed that a non-specific inhibitor of cyclooxygenases reduced the expression of COL10A1. In contrast, inhibitors of protein kinases stimulated the expression of COL10A1. Furthermore, potent and selective inhibitors of COX-1 and 5-LOX also reduced the expression of COL10A1. However, COX-2 and 12-LOX inhibitors had no significant effect on the expression of COL10A1. COX-1 gene expression was also decreased when MSCs were incubated on “S5” PPE:N surfaces. Interestingly, MSCs did not express 5-LOX. Conclusion: PPE:N surfaces suppress COL10A1 expression through the inhibition of COX-1 which is directly implicated in the synthesis of prostaglandins. The decreased expression of COX-1 and COL10A1 in human MSCs cultured on PPE:N is therefore in agreement with the induction of the osteogenic capacity of rat bone marrow and bone formation by systemic or local injection of PGE2 in rats. However, PGE2 and other prostaglandins inhibited COL10A1 expression in chick growth plate chondrocytes. This suggests that the effect of prostaglandins on COL10A1 expression may be cell-specific or may be dependent on pre-existing patho-physiological conditions.

Sphingosine 1-phosphate receptors negatively regulate collagen type I/III expression in human bone marrow-derived mesenchymal stem cell

Proportion of collagen type II in the extracellular matrix promotes the differentiation of human adipose‐derived mesenchymal stem cells into nucleus pulposus cells

Growth and Proliferation of Bone Marrow Mesenchymal Stem Cells Affected by Type I Collagen, Fibronectin and Bfgf

18 Alpha-Glycyrrhetinic Acid Down-Regulates Expression Of Type I And Iii Collagen Via Tgf-B1/Smad Signaling Pathway In Human And Rat Hepatic Stellate Cells

Regulation of the Secretion of Immunoregulatory Factors of Mesenchymal Stem Cells (mscs) by Collagen-Based Scaffolds During Chondrogenesis.

TNF-α and IL-1β inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells

Sika pilose antler type I collagen promotes BMSC differentiation via the ERK1/2 and p38-MAPK signal pathways

Effect of agonists and inhibitors of matrix metalloproteinases on expression of matrix metalloproteinase 1/2 and collagen Ⅰ in human scleral fibroblast

Collagen structure regulates MSCs behavior by MMPs involved cell–matrix interactions

Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells

Diverse effects of type II collagen on osteogenic and adipogenic differentiation of mesenchymal stem cells

18α-glycyrrhetinic acid down-regulates expression of type I and III collagen via TGF-Β1/Smad signaling pathway in human and rat hepatic stellate cells.

Effect of Type I Collagen on the Adhesion, Proliferation, and Osteoblastic Gene Expression of Bone Marrow-Derived Mesenchymal Stem Cells

RhoA, Rac1, and Cdc42 differentially regulate αSMA and collagen I expression in mesenchymal stem cells

Role of Integrin ß1 and Tenascin C Mediate TGF-SMAD2/3 Signaling in Chondrogenic Differentiation of BMSCs Induced by Type I Collagen Hydrogel

5. MECHANISM OF DECREASED EXPRESSION OF TYPE X COLLAGEN IN HUMAN MESENCHYMAL STEM CELLS CULTURED ON NITROGEN-RICH PLASMA POLYMERS: IMPLICATION OF CYCLOOXYGENASE-1

Vitronectin and collagen I differentially regulate osteogenesis in mesenchymal stem cells

Exogenous dihydrosphingosine 1 phosphate mediates collagen synthesis in cardiac fibroblasts through JAK/STAT signalling and regulation of TIMP1

Collagen hydrogel viscoelasticity regulates MSC chondrogenesis in a ROCK-dependent manner

Experimental study on proliferation and collagen synthesis in hepatic stellate cells regulated by bone marrow mesenchymal stem cells

Effect of Parathyroid Hormone on Type X and Type II Collagen Expression in Mesenchymal Stem Cells from Osteoarthritic Patients